What is Northland Capmk's Forecast for Transcat Q3 Earnings?

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Equities researchers at Northland Capmk reduced their Q3 2025 EPS estimates for shares of Transcat in a research note issued on Monday, December 16th. Northland Capmk analyst E. Jackson now forecasts that the scientific and technical instruments company will earn $0.33 per share for the quarter, down from their prior forecast of $0.41. The consensus estimate for Transcat's current full-year earnings is $1.76 per share. Northland Capmk also issued estimates for Transcat's Q4 2025 earnings at $0.51 EPS and FY2025 earnings at $1.68 EPS.

Several other analysts have also weighed in on the company. HC Wainwright restated a "buy" rating and issued a $156.00 price objective on shares of Transcat in a report on Tuesday, October 29th. Craig Hallum raised their price objective on shares of Transcat from $113.00 to $125.00 and gave the company a "buy" rating in a research report on Thursday, December 12th. StockNews.com downgraded shares of Transcat from a "hold" rating to a "sell" rating in a report on Tuesday, October 29th. Oppenheimer restated an "outperform" rating and set a $130.00 target price (down from $155.00) on shares of Transcat in a report on Wednesday, October 30th. Finally, Northland Securities dropped their price target on Transcat from $130.00 to $110.00 and set a "market perform" rating on the stock in a report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $130.25.

Transcat Stock Down 5.0 %

NASDAQ TRNS traded down $5.51 on Wednesday, reaching $103.99. 74,673 shares of the stock traded hands, compared to its average volume of 55,200. Transcat has a 12 month low of $94.29 and a 12 month high of $147.12. The company has a market cap of $956.60 million, a price-to-earnings ratio of 52.52 and a beta of 0.70. The firm's fifty day simple moving average is $110.94 and its 200 day simple moving average is $119.06.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The company had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. During the same quarter last year, the business earned $0.41 earnings per share. The company's revenue was up 8.0% on a year-over-year basis.

Institutional Trading of Transcat

Several large investors have recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC boosted its position in shares of Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company's stock worth $109,561,000 after buying an additional 137,830 shares during the period. Champlain Investment Partners LLC boosted its position in Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company's stock worth $49,455,000 after acquiring an additional 74,169 shares during the period. Royce & Associates LP grew its stake in Transcat by 8.2% during the 3rd quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company's stock valued at $61,798,000 after acquiring an additional 38,774 shares in the last quarter. Hood River Capital Management LLC increased its holdings in shares of Transcat by 21.6% in the 2nd quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company's stock valued at $23,558,000 after purchasing an additional 34,947 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its position in shares of Transcat by 28.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company's stock worth $9,577,000 after purchasing an additional 17,743 shares in the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.